Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.450 | 0.540 | 0.090 |
Stocks | 99.660 | 99.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.538 | 17.752 |
Price to Book | 2.809 | 2.850 |
Price to Sales | 1.536 | 2.017 |
Price to Cash Flow | 12.350 | 11.625 |
Dividend Yield | 1.923 | 2.102 |
5 Years Earnings Growth | 10.296 | 10.934 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 28.530 | 14.345 |
Technology | 25.060 | 22.040 |
Financial Services | 12.790 | 15.459 |
Consumer Cyclical | 9.910 | 10.686 |
Industrials | 8.340 | 12.082 |
Communication Services | 6.960 | 7.248 |
Consumer Defensive | 5.400 | 8.440 |
Real Estate | 1.550 | 2.817 |
Basic Materials | 1.460 | 4.364 |
Number of long holdings: 62
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.92 | 420.99 | -0.49% | |
Alphabet A | US02079K3059 | 5.11 | 174.11 | +0.93% | |
UnitedHealth | US91324P1021 | 4.35 | 521.27 | +0.72% | |
AstraZeneca | GB0009895292 | 3.70 | 12,166.0 | -0.05% | |
Fiserv | US3377381088 | 3.18 | 152.84 | -1.40% | |
AbbVie | US00287Y1091 | 2.94 | 164.33 | +0.33% | |
ASML Holding | NL0010273215 | 2.93 | 859.10 | +0.95% | |
Roche Holding Participation | CH0012032048 | 2.78 | 234.80 | +3.21% | |
Novartis | CH0012005267 | 2.76 | 92.62 | -0.73% | |
CVS Health Corp | US1266501006 | 2.63 | 57.52 | +2.24% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lan & Spar Invest - Danske Aktier | 1.06B | 4.21 | -1.77 | 7.94 | ||
Lan & Spar Invest - Europa Classics | 146.76M | 11.92 | 12.91 | 4.79 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review